-

12:09:11 PM

HBIO Stock News

HBIO - Harvard Bioscience Inc.

09/18/23 8:57 AM

Nasdaq : HBIO

clinical trial

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept. 18, 2023

RHEA-AI

positive

08/08/23 7:18 AM

Nasdaq : HBIO

earnings

Harvard Bioscience Announces Second Quarter 2023 Financial Results

Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today

RHEA-AI

neutral

08/03/23 6:30 PM

Nasdaq : HBIO

conferences

Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023

Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the

RHEA-AI

neutral

07/27/23 6:36 PM

Nasdaq : HBIO

earnings

Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET

Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2023 before the market opens on August 8, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.

RHEA-AI

neutral

06/22/23 7:55 AM

Nasdaq : HBIO

Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes

Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that it is set to join the Russell 2000 ® and Russell 3000 Indexes, according to preliminary membership information posted to the FTSE Russell website. The addition is

RHEA-AI

positive

06/20/23 8:01 AM

Nasdaq : HBIO

management

Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer

Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer and Treasurer, effective June 19, 2023. Cote joined

RHEA-AI

very positive

05/02/23 5:01 PM

Nasdaq : HBIO

Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023

Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Micro Cap Virtual Conference taking place on May 10th, 2023. Mr.

RHEA-AI

neutral

04/25/23 8:01 AM

Nasdaq : HBIO

earnings

Harvard Bioscience Announces First Quarter 2023 Financial Results

Harvard Bioscience, Inc.

RHEA-AI

neutral

04/18/23 5:10 PM

Nasdaq : HBIO

Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System

Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral monitoring system

RHEA-AI

very positive

04/17/23 4:45 PM

Nasdaq : HBIO

earnings

Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET

Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April 25, 2023, and will hold a conference call to discuss the results at 9:00 a.m. Eastern Time.

RHEA-AI

neutral

HBIO Data

IndustryAnalytical Laboratory Instrument Manufacturing
Websitehttps://www.harvardbioscience.com/
Security nameHarvard Bioscience Inc.
SectorManufacturing
Tags
- Health Technology
- Biotechnology
- Manufacturing
- Analytical Laboratory Instrument Manufacturing
CountryUS

About Harvard Bioscience Inc.

harvard bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. we sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including ge healthcare, thermo fisher scientific inc., and vwr. we have sales and manufacturing operations in the united states, the united kingdom, germany, and spain and sales facilities in france and canada.